Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial
BMC Nephrology - United Kingdom
doi 10.1186/s12882-015-0130-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 16, 2015
Authors
Publisher
Springer Science and Business Media LLC